| Acquirer | Target | Price |
|---|---|---|
| Allergan plc | License to 5 genome-editing ocular programs | $90 million |
| HMS Holdings Corp. | Eliza Corporation | $170 million |
| National Health Investors, Inc. | Assisted living/memory care community | $26.2 million |
| American Securities LLC | Air Methods Corporation | $2.48 billion |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
